Edition:
United States

Abbott Laboratories (ABT)

ABT on New York Consolidated

49.27USD
22 Jun 2017
Change (% chg)

$0.70 (+1.44%)
Prev Close
$48.57
Open
$48.60
Day's High
$49.59
Day's Low
$48.51
Volume
8,714,052
Avg. Vol
6,982,581
52-wk High
$49.59
52-wk Low
$36.76

ABT

Chart for ABT

About

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded... (more)

Overall

Beta: 1.58
Market Cap(Mil.): $84,282.16
Shares Outstanding(Mil.): 1,735.27
Dividend: 0.26
Yield (%): 2.18

Financials

  ABT Industry Sector
P/E (TTM): 53.92 13.97 18.98
EPS (TTM): 0.90 -- --
ROI: 2.93 -6.80 -5.09
ROE: 5.35 -6.26 -4.32

BRIEF-Abbott sets quarterly dividend of $0.265 per share

* Sets quarterly dividend of $0.265 per share Source text for Eikon: Further company coverage:

Jun 09 2017

BRIEF-Alere Q4 loss per share $1.38 from continuing operations

* Alere files form 10-k, reports fourth quarter and full year 2016 financial results

Jun 05 2017

Abbott trial win in stent whistleblower lawsuit upheld on appeal

A federal appeals court has upheld Abbott Laboratories' trial win in a potentially billion-dollar whistleblower lawsuit over off-label promotion of bile duct stents for use in blood vessels.

Jun 01 2017

BRIEF-Abbott reports CE Mark for tacticath contact force ablation catheter

* Abbott announces CE Mark for tacticath™ contact force ablation catheter, sensor enabled™

May 09 2017

BRIEF-Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac monitor

* Abbott announces CE mark and first use of the world's first smartphone compatible insertable cardiac monitor

May 08 2017

China's richest man deepens sports foray with global marathons deal

BEIJING China's Dalian Wanda Group, controlled by the country's richest man Wang Jianlin, has signed a deal to sponsor races with the world's top organizer, Abbott World Marathon Majors (WMM), the latest move by Wanda to expand its global sports business.

Apr 26 2017

CORRECTED-OFFICIAL-China's richest man deepens sports foray with global marathons deal

BEIJING, April 26 China's Dalian Wanda Group, controlled by the country's richest man Wang Jianlin, has signed a deal to sponsor races with the world's top organizer, Abbott World Marathon Majors (WMM), the latest move by Wanda to expand its global sports business.

Apr 26 2017

BRIEF-Abbott Laboratories develops 2 new science-based nutrition drinks for patients undergoing surgery

* Abbott Laboratories - developed two new science-based nutrition drinks for patients undergoing surgery Source text for Eikon: Further company coverage:

Apr 26 2017

Abbott sees Alere as challenging 'fixer-upper' after revised deal

Abbott Laboratories said it was looking to close the recently revised deal to buy Alere Inc in the coming months, calling the diagnostics company "a bit of a fixer-upper".

Apr 19 2017

UPDATE 3-Abbott sees Alere as challenging "fixer-upper" after revised deal

* Closing of new Alere deal is a little unpredictable - CFO (Adds conference call details; Updates shares)

Apr 19 2017

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $136.05 +1.14
Pfizer Inc. (PFE.N) $34.06 +0.18
Novartis AG (NOVN.S) CHF83.80 +3.95
Merck & Co., Inc. (MRK.N) $66.02 +0.56
Sanofi SA (SASY.PA) €88.65 +2.09
AstraZeneca plc (AZN.L) 5,508.00 +108.00
GlaxoSmithKline plc (GSK.L) 1,722.00 +39.00
Eli Lilly and Co (LLY.N) $84.31 +1.67
Amgen, Inc. (AMGN.OQ) $173.82 +2.47
Boston Scientific Corporation (BSX.N) $27.86 -0.05

Earnings vs. Estimates